Hints and tips:
...You would think it was part of a script from a budget B-movie if it wasn’t so true”....
...Next year it expects to increase the flow through its Edmonton rail terminal to 170,000 b/d, from 80,000 b/d earlier this year....
...Next up:Over the past two years, company D has spent an amount on buybacks equal to 85% of a year’s ebitda....
...It comes up for most big mergers these days: if big company A does not — or is not allowed — to buy big company B, even bigger companies C or D will crush both....
...“I said I’d go and sort it out myself,” explains Mr McCabe. Expecting a drab industrial city, he was astonished by the pace of development there and in Beijing....
...The sale to Three was instead “Plan B” and something Mr Dunne found surprising. “I never saw a deal with Three as likely to happen....
...When the merger was called off, in May last year, Publicis was forced into extending Mr Lévy’s tenure, buying valuable time to come up with a plan B....
...From a year-on-year figure of 2.2m b/d at the start of 2015, it has slowed to 300,000 b/d in November, according to the International Energy Agency....
...His tall frame, silky French accent and Cote d’Azur complexion oozes charm....
...“They said everything would be fine if I sold down below 30 per cent,” Judy said, “But the news spread and the B&B filled up with M&A bankers....
...“Such a deal has strategic logic and meaningful synergies but we’d imagine investors would see it as opportunistic rather than imperative,” said Jefferies....
...It now expects output to rise by about 150,000 barrels per day this year to about 3.6m b/d, and by a further 150,000 b/d next year....
...Actelion, the Swiss biotech company, and Alkermes, an Irish-based drugmaker, were both down at least 2.5 per cent....
...($0.90) Telefónica FY €0.83 (€0.99) TJX Companies Q4 $0.90 ($0.81) EARNINGS ACS FY €2.25 (€2.20) Ahold FY (Q3 estimate) €0.89 (€0.92) Allianz FY €13.91 (€13.05) Ambev Q4 R0.30 (R0.30) Anheuser-B...
...of R&D investment large drugmakers should fund....
...Firm B had a short position of €50m. Firm C, a buyer, netted off with Firm A and Firm B, leaving it with €10m to buy at the fix. Firm B then advised Firm C to “go late”, when the rate will be lower....
...Production, peaked at 3.4m barrels a day in 2004, but has since fallen 24 per cent to 2.5m b/d this year, say the authors of a Boston Consulting Group (BCG) report on Mexico’s energy reforms....
...The Company does not have a stockholder rights plan in effect. (d) Other Rights....
...Among them was Zoetis, the animal health group in which he recently amassed a stake and suggested as a Plan B target....
...Companies including Horizon Pharma, Perrigo, Actavis, Alkermes, Jazz Pharmaceuticals, Covidien, Forest Laboratories and Endo Health Solutions have moved to Ireland, in deals expected to cut companies’ overall...
...B: Dennis Rodman got in first as Kim Jong-un’s Best Friend in the west. C: I’d say you should try the Middle East, except you’re a peace envoy. That could create conflicts....
...Besides Endo, recent similar inversion examples include Perrigo, Horizon Pharma, Actavis, Alkermes, Jazz Pharmaceuticals, Covidien and Forest Laboratories....
...the virtues of the deal, claiming it is a “win-win” for society, then say it will mean job losses and big cuts in R&D The target says they will not accept anything less than £58.85, 10 per cent higher...
...produce 500,000 b/d....
...Others, however, say UK reluctance means Scotland is likely to have to come up with a Plan B....
International Edition